[ Price : $8.95]
FDA issues a safety alert recommending that healthcare providers not use BioZorb Markers and BioZorb LP Markers manufactured by Ho...[ Price : $8.95]
FDA approves an Iterum Therapeutics NDA for Orlynvah (sulopenem etzadroxil and probenecid) for treating certain uncomplicated urin...[ Price : $8.95]
FDA grants Kind Pharmaceutical an orphan drug designation for AND017 and its use in treating sickle cell disease.[ Price : $8.95]
Smiths Medical recalls specific lots of its BLUSelect, BLUgriggs, and BLUperc products due to a manufacturing defect.[ Price : $8.95]
PhRMA and USP recommend that FDA develop product class-specific guidances rather than product-specific guidances to spur the devel...[ Price : $8.95]
Federal Register notice: FDA announces a 12/4 Pharmacy Compounding Advisory Committee meeting to discuss various bulk drug substan...[ Price : $8.95]
Intellia Therapeutics reports positive data from the ongoing Phase 1/2 study of NTLA-2002, a CRISPR-based gene editing therapy, in...[ Price : $8.95]
The Public Citizen Health Research Group calls for a federal investigation into clinical trials for two Alzheimers drugs that may ...